Valinor Pharma
Manufacturing · Illinois, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
150 N Riverside Plz Ste 3410, Chicago, I...Phone Number
(833) 233-0115Website
www.valinorrx.comRevenue
<$5 MillionIndustry
About Valinor Pharma
Valinor Pharma Org Chart
Is Valinor Pharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Valinor Pharma, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Valinor Pharma has new funding data
Earning: See what the market has to say on Valinor Pharma recently announced quarterly report
Check out if Valinor Pharma is spiking on competitors!
Click to see if Valinor Pharma had a recent Job posting/layoffs
Product Launch: Get notified when Valinor Pharma launches new products
Congratulate Masked Content for being promoted to Masked Content at Valinor Pharma
Check if Valinor Pharma has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Reach out to Masked Content who joined Valinor Pharma as Masked Content
Find more new buyers
Company Profile Activity
Activity Insights
Valinor Pharma is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Valinor Pharma is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Valinor Pharma.
Valinor Pharma Tech Stack
A closer look at the technologies used by Valinor Pharma
Valinor Pharma News & Media
Valinor Pharma Announces Acquisition by Grünenthal with a Total Deal Value of Approximately $250 Million
Grünenthal acquires Valinor Pharma in an all-stock deal and becomes the owner of the global rights to Movantik® (naloxegol) Valinor Pharma had owned Movantik since early 2023 and leveraged Apollo Care's commercial platform to grow Movantik volume in the U.S. while reducing gross-to-net...Grünenthal acquires US-company Valinor Pharma and becomes global owner of Movantik®
Grünenthal acquires the pharmaceutical company Valinor Pharma, further strengthening Grünenthal's footprint in the United States. With the acquisition, Grünenthal becomes the global owner of Movantik® / Moventig® (naloxegol). Since 2017, Grünenthal has invested more than €2 billion in...RedHill Biopharma Reaches Agreement in Principle with HCR to Extinguish All Debt Obligations in Exchange for Movantik®
TEL AVIV, Israel and RALEIGH, N.C., Nov. 14, 2022 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that it has reached a non-binding agreement in principle with HCR Collateral Management, LLC ("HCR")...RedHill Biopharma's Movantik® Added as Preferred and Unrestricted Brand To Major National Medicare Formulary Serving Millions of Americans
TEL AVIV, Israel and RALEIGH, N.C., Dec. 1, 2021 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that one of America's largest payors, serving more than 10 million Americans through multiple...
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Valinor Pharma
Valinor Pharma is a pharmaceutical company dedicated to the innovative commercialization of medicines that provide meaningful benefits to patients while ensuring accessibility and affordability. Their mission centers around delivering significant value to patients, healthcare providers, and investors by overcoming market challenges that hinder medi... Read More